Management strategies for PMS/PMDD.
Yonkers
Kimberly A
KA
Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
D003276:Contraceptives, Oral / Q000627:therapeutic use*; D005260:Female; D005473:Fluoxetine / Q000627:therapeutic use*; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists* / Q000502:physiology; D006801:Humans; D011293:Premenstrual Syndrome / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D016032:Randomized Controlled Trials as Topic; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*
D003276:Contraceptives, Oral; D005473:Fluoxetine; D007987:Gonadotropin-Releasing Hormone; D017367:Selective Serotonin Reuptake Inhibitors